The global medical device reprocessing market involves the cleaning, disinfection, and sterilization of single-use medical devices for their safe reuse. This sustainable practice aims to reduce healthcare costs, medical waste, and environmental impact. As healthcare providers seek efficient ways to manage resources, the reprocessing market has gained prominence. It encompasses various medical devices, including surgical instruments, diagnostic equipment, and accessories. Overall, the global medical device reprocessing market reflects a dynamic landscape shaped by the intersection of economic, environmental, and healthcare industry factors.
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/global-medical-device-reprocessing-market
Data Bridge Market Research analyses that the Global Medical Device Reprocessing Market, which was USD 3,599.7 million in 2022, would rise to USD 12,726.91 million by 2030 and is expected to undergo a CAGR of 17.10% during the forecast period 2023 to 2030. Increased awareness and education within the healthcare sector have played a pivotal role in fostering acceptance of medical device reprocessing. Healthcare professionals and institutions, better informed about the economic and environmental benefits, increasingly recognize reprocessing as a valuable and sustainable practice for cost-effective and responsible healthcare management.
Key Findings of the Study
Pressure to reduce healthcare costs is expected to drive the market's growth rate
The escalating challenge of controlling healthcare expenses, exacerbated by growing patient numbers and chronic conditions, compels the healthcare industry to embrace cost-saving strategies. In response to this financial pressure, the adoption of practices such as medical device reprocessing has gained prominence. Recognized as a viable solution, reprocessing allows healthcare providers to curtail expenditures without compromising quality, aligning with the overarching objective of achieving efficient and sustainable cost management in the healthcare sector.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Enzymatic, Non-Enzymatic Detergent), Product and Service (Reprocessing Support and Services, Reprocessed Medical Devices), Process (Presoak, Manual Cleaning, Automatic Cleaning, Disinfection), Devices Type (Critical Devices, Semi-Critical Devices, Non-Critical Devices), Application (Devices, Accessories), End User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Manufacturers, Ambulatory Surgical Centers, Others)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Stryker (U.S.), Cardinal Health (U.S.), Johnson & Johnson Private Limited (U.S.), Baxter (U.S.), 3M (U.S.), Cantel Medical (U.S.), STERIS (U.S.), EverX (U.S.), Vanguard AG (U.S.), Avante Health Solutions (U.S.), SteriPro (Canada), Getinge AB (Sweden), SureTek Medical (U.S.), SOMA TECH INTL (U.S.), Olympus Corporation (Japan), Medtronic (Ireland), Pioneer Medical Devices AG (Germany)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global medical device reprocessing market is categorized into six notable segments which are based on the type, product and service, process, devices type, application, and end user.
- On the basis of type, the global medical device reprocessing market is segmented into enzymatic and non-enzymatic detergent. Enzymatic segment is expected to dominate the market with a 63.51% market share due to the rise in pressure to reduce the volume of regulated medical waste
Enzymatic segment is expected to dominate the medical device reprocessing market
The enzymatic segment is expected to dominate the market with a 63.51% market share due to the rise in pressure to reduce the volume of regulated medical waste and minimize healthcare expenditure. The enzymatic approach proves pivotal in aligning with these objectives, driving its prominence in the medical device reprocessing market.
- On the basis of product and service, the global medical device reprocessing market is segmented into reprocessing support and services and reprocessed medical devices. The reprocessing support and services segment is expected to dominate the market with an 82.70% market share as these reprocessed medical devices lead to significant savings in the healthcare sector, help in minimizing infection and are equally efficient as the original device
- On the basis of process, the global medical device reprocessing market is segmented into presoak, manual cleaning, automatic cleaning, and disinfection. The disinfection segment is expected to dominate the market with a 49.0% market share due to the rise in pressure to reduce volume of regulated medical waste
- On the basis of devices type, the global medical device reprocessing market is segmented into critical devices, semi-critical devices, and non-critical devices. The non-critical devices segment is expected to dominate the market with a 62.8% market share due to the rise in medical waste and hospital infections
Non-critical devices segment is expected to dominate the medical device reprocessing market
Non-critical devices segment is expected to dominate the market with a 62.8% market share due to the rise in medical waste and hospital infections. The emphasis on infection control and waste reduction propels the preference for reprocessing non-critical medical devices, establishing it as a prominent and pivotal market segment.
- On the basis of application, the global medical device reprocessing market is segmented into devices and accessories. The devices segment is expected to dominate the market with a 78.0% market share as these devices lead to significant savings in the healthcare sector
- On the basis of end user, the global medical device reprocessing market is segmented into hospitals, clinics, home healthcare, diagnostic centers, manufacturers, ambulatory surgical centers, and others. The hospitals segment is expected to dominate the market with a 39.3% market share due to the increase in sudden adaptation and demand for reprocessed medical devices in hospitals
Major Players
Data Bridge Market Research recognizes the following companies as the major global medical device reprocessing market players in global medical device reprocessing market are Avante Health Solutions (U.S.), SteriPro (Canada), Getinge AB (Sweden), SureTek Medical (U.S.), SOMA TECH INTL (U.S.), Olympus Corporation (Japan), Medtronic (Ireland), Pioneer Medical Devices AG (Germany)
Market Developments
- In 2022, the Association of Medical Device Reprocessors launched "Global Regulatory Standards for 'Single-Use' Medical Device Reprocessing and Remanufacturing." It is the first roadmap to assist Notified Bodies, Ministries of Health, and regulatory authorities of medical devices to access its global benefits for hospitals and health systems
- In 2021, Zionexa, a top developer of in-vivo cancer and neurology biomarkers, was acquired by General Electric Healthcare. With this purchase, businesses are able to provide more individualized healthcare. The business intends to market the biomarkers in Zionexa's pipeline as well as the recently FDA-approved PET imaging agent CeriannaTM (fluoroestradiol F-18), which is used in conjunction with a biopsy to identify oestrogen receptor (ER) positive lesions and aid patients with metastatic or recurrent breast cancer in making treatment choices
- In 2021, Stryker announced a multiyear, nationwide partnership with minor league baseball, designating the company as the official smart robotics joint replacement partner. As part of its dedication to enhancing healthcare and as part of a larger MiLB partnership, Stryker is also the presenting partner of "Own the Walk," the first-ever nationwide initiative that encourages fans of all ages to stay active through regular activities such as walking. This partnership offers a solid foundation for future development and renown
Regional Analysis
Geographically, the countries covered in the global medical device reprocessing market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
As per Data Bridge Market Research analysis:
North America is the dominant region in the global medical device reprocessing market during the forecast period 2023-2030
North America dominates the global medical device reprocessing market, propelled by key players and a robust GDP. The region's market leadership is fortified by active engagement in PDA guidelines and a dynamic landscape of reprocessed medical devices. These factors collectively contribute to an accelerated growth rate, establishing North America as a pivotal hub for advancements and adherence to evolving industry standards in the medical device reprocessing sector.
Asia-Pacific is estimated to be the fastest-growing region in the global medical device reprocessing market in the forecast period 2023-2030
Asia-Pacific is expected to dominate the global medical device reprocessing market, driven by substantial technological advancements in automation and a rapid increase in product usage. The region's market growth is further propelled by heightened awareness surrounding reprocessed medical devices. This confluence of technological innovation and increasing awareness positions Asia-Pacific as a significant contributor to the expansion of the global market for medical device reprocessing.
For more detailed information about the global medical device reprocessing market report, click here – https://www.databridgemarketresearch.com/ar/reports/global-medical-device-reprocessing-market
